An online survy on recognition and present status of disease modifying therapy (DMT) for dementia in Japan ; the Japanese Society for Neurological Therapeutics

Abstract

In introducing disease modifying therapy (DMT) for Alzheimer disease, Japanese Society for Neurological Therapeutics (JSNT) has investigated online survey for JSNT menbers concerning on recognition and present status of DMT. Ninty eight % of the response was obtained from neurologist and the response rare was 48.9% (298/609). Majority of instituitututions planed to introduce DMT (63%), and select amyloid PET (77%) as as a diagnostic method. This survey may provide a useful tool for facilitating introduction of DMT for Alzheimer disease in Japan.